Cargando…

Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis

Increased exposure of calreticulin (CALR) on malignant cells is associated with therapy-relevant adaptive immune responses and superior therapeutic outcome in solid tumors and haemato-oncological diseases, because surface-exposed CALR acts as an ‘eat-me’ signal facilitating the phagocytosis of stres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kepp, Oliver, Liu, Peng, Zhao, Liwei, Plo, Isabelle, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458660/ https://www.ncbi.nlm.nih.gov/pubmed/32923154 http://dx.doi.org/10.1080/2162402X.2020.1792037

Ejemplares similares

Secreted calreticulin mutants subvert anticancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2019)

Conventional type 1 dendritic cells (cDC1) in cancer immunity
por: Liu, Peng, et al.
Publicado: (2023)

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2022)

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
por: Wemeau, M, et al.
Publicado: (2010)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
por: Kasikova, Lenka, et al.
Publicado: (2019)

Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
por: Tian, Ai-Ling, et al.
Publicado: (2021)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!
por: Kepp, Oliver, et al.
Publicado: (2020)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
por: Kroemer, Guido, et al.
Publicado: (2021)

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin
por: Gong, Fang-Yuan, et al.
Publicado: (2018)

Self-Oligomerization Is Essential for Enhanced Immunological Activities of Soluble Recombinant Calreticulin
por: Huang, Shang-Hui, et al.
Publicado: (2013)

A genotype-phenotype screening system using conditionally immortalized immature dendritic cells
por: Zhao, Liwei, et al.
Publicado: (2021)

Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018)

Assessment of Roles for Calreticulin in the Cross-Presentation of Soluble and Bead-Associated Antigens
por: Del Cid, Natasha, et al.
Publicado: (2012)

Calreticulin: Roles in Cell-Surface Protein Expression
por: Jiang, Yue, et al.
Publicado: (2014)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Mitochondrial regulation of cell death: a phylogenetically conserved control
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases
por: Chen, Guo, et al.
Publicado: (2020)

AKT as a therapeutic target for autophagy induction and cancer therapy
por: Wu, Qi, et al.
Publicado: (2021)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy
por: Bourgin, Melanie, et al.
Publicado: (2022)

Impact of local anesthetics on epigenetics in cancer
por: Bezu, Lucillia, et al.
Publicado: (2022)

Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
por: Kepp, Oliver, et al.
Publicado: (2023)

Late-stage inhibition of autophagy enhances calreticulin surface exposure
por: Li, Dan-Dan, et al.
Publicado: (2016)

From the archives: Cold acclimation by plastid translation, metabolic allocation, and plant defense, and functions of a BiP–calreticulin complex
por: Frungillo, Lucas
Publicado: (2023)

Calreticulin and the Heart
por: Groenendyk, Jody, et al.
Publicado: (2022)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

An unexpected link between immunogenic cell death and inhibition of gene transcription
por: Humeau, Juliette, et al.
Publicado: (2020)

Metabolic Profiling of CHO Cells during the Production of Biotherapeutics
por: Coulet, Mathilde, et al.
Publicado: (2022)

Immunological Effects of Epigenetic Modifiers
por: Bezu, Lucillia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rboscatomqkr6h49psf4udluc4